Summary:

Traditional vaccine evaluation often relies on binding or neutralization titers, yet these measures fail to capture the full spectrum of antibody functions that drive protection. SeromYx’s systems serology platform delivers the most comprehensive view of Fc-mediated effector functions, enabling developers to uncover correlates of protection, optimize lead selection, and de-risk clinical development. 

Drawing on case studies from malaria, COVID-19, and more, this talk will highlight how functional antibody profiling reveals protective signatures overlooked by standard assays, and how these insights are reshaping next-generation vaccine and immunotherapeutic design. Attendees will gain a practical understanding of why going beyond binding is essential for tackling complex pathogens and advancing more effective, durable interventions.